Casa-Dea Finance will acquire BDC’s $9 million claim against Spartan and a numbered firm controlled by its director will buy most of its assets
This was bound to be a risky proceeding. When Spartan Bioscience filed for court protection last April, it had been racing on multiple fronts to chase a once-in-a-lifetime opportunity. Read More